Cargando…

Paper 36: Levels of Synovial Fluid Cytokines Predict Midterm Patient Reported Outcomes Following Arthroscopic Partial Meniscectomy

OBJECTIVES: To identify synovial fluid biomarkers associated with midterm postoperative outcomes in patients undergoing arthroscopic partial meniscectomy (APM). METHODS: Subjects were prospectively enrolled in a cohort of patients who had synovial fluid aspirated from their knee on the day of surger...

Descripción completa

Detalles Bibliográficos
Autores principales: Shankar, Dhruv, Vasavada, Kinjal, Kingery, Matthew, Montgomery, Samuel, Buzin, Scott, Chan, Calvin, Jazrawi, Laith, Strauss, Eric, Avila, Amanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392310/
http://dx.doi.org/10.1177/2325967123S00062
_version_ 1785082928162668544
author Shankar, Dhruv
Vasavada, Kinjal
Kingery, Matthew
Montgomery, Samuel
Buzin, Scott
Chan, Calvin
Jazrawi, Laith
Strauss, Eric
Avila, Amanda
author_facet Shankar, Dhruv
Vasavada, Kinjal
Kingery, Matthew
Montgomery, Samuel
Buzin, Scott
Chan, Calvin
Jazrawi, Laith
Strauss, Eric
Avila, Amanda
author_sort Shankar, Dhruv
collection PubMed
description OBJECTIVES: To identify synovial fluid biomarkers associated with midterm postoperative outcomes in patients undergoing arthroscopic partial meniscectomy (APM). METHODS: Subjects were prospectively enrolled in a cohort of patients who had synovial fluid aspirated from their knee on the day of surgery prior to undergoing APM. Biomarker analysis was performed. Preoperative patient-reported outcome (PRO) scores including VAS pain, Lysholm and Tegner activity score were collected preoperatively. At a minimum of 2 years of follow-up postoperative outcomes were collected. Using previously described values, patients who met the minimal clinically important difference (MCID) for Lysholm score were identified and groups were compared using parametric and non-parametric tests. Using preoperative and postoperative outcome scores, generalized linear models were used to explore the relationship between biomarkers and improvement in Lysholm Score, improvement in visual analog scale (VAS) pain score, and postoperative KOOS-PS. RESULTS: Fifty patients were included in the study. 34 (68%) met the MCID for the Lysholm score and 16 (32%) did not. Mean age was 51 ± 9 years for the entire cohort, with no statically significant differences between the groups (p=0.35). Both groups were majority male (p=0.37) and there were no differences in BMI (0.74) or follow-up time (p=0.20). On logistic regression, increased concentration of RANTES (β = -6.30, p = 0.04) and MMP-3 (β = -15.16, p = 0.001) were predictive of less improvement in VAS pain. . For Lysholm score, higher SF levels of IL-1 RA were predictive of greater improvement (β = 12.57, p = 0.04) while higher levels of MMP-3 were predictive of reduced improvement (β = -10.34, p = 0.007). CONCLUSIONS: This study found that at the time of surgery, intraarticular levels of MMP-3 and RANTES are predictive of poorer midterm outcomes and higher pain levels following APM. Additionally, higher levels of IL-1RA at the time of surgery were associated with greater improvement in midterm Lysholm score.
format Online
Article
Text
id pubmed-10392310
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-103923102023-08-02 Paper 36: Levels of Synovial Fluid Cytokines Predict Midterm Patient Reported Outcomes Following Arthroscopic Partial Meniscectomy Shankar, Dhruv Vasavada, Kinjal Kingery, Matthew Montgomery, Samuel Buzin, Scott Chan, Calvin Jazrawi, Laith Strauss, Eric Avila, Amanda Orthop J Sports Med Article OBJECTIVES: To identify synovial fluid biomarkers associated with midterm postoperative outcomes in patients undergoing arthroscopic partial meniscectomy (APM). METHODS: Subjects were prospectively enrolled in a cohort of patients who had synovial fluid aspirated from their knee on the day of surgery prior to undergoing APM. Biomarker analysis was performed. Preoperative patient-reported outcome (PRO) scores including VAS pain, Lysholm and Tegner activity score were collected preoperatively. At a minimum of 2 years of follow-up postoperative outcomes were collected. Using previously described values, patients who met the minimal clinically important difference (MCID) for Lysholm score were identified and groups were compared using parametric and non-parametric tests. Using preoperative and postoperative outcome scores, generalized linear models were used to explore the relationship between biomarkers and improvement in Lysholm Score, improvement in visual analog scale (VAS) pain score, and postoperative KOOS-PS. RESULTS: Fifty patients were included in the study. 34 (68%) met the MCID for the Lysholm score and 16 (32%) did not. Mean age was 51 ± 9 years for the entire cohort, with no statically significant differences between the groups (p=0.35). Both groups were majority male (p=0.37) and there were no differences in BMI (0.74) or follow-up time (p=0.20). On logistic regression, increased concentration of RANTES (β = -6.30, p = 0.04) and MMP-3 (β = -15.16, p = 0.001) were predictive of less improvement in VAS pain. . For Lysholm score, higher SF levels of IL-1 RA were predictive of greater improvement (β = 12.57, p = 0.04) while higher levels of MMP-3 were predictive of reduced improvement (β = -10.34, p = 0.007). CONCLUSIONS: This study found that at the time of surgery, intraarticular levels of MMP-3 and RANTES are predictive of poorer midterm outcomes and higher pain levels following APM. Additionally, higher levels of IL-1RA at the time of surgery were associated with greater improvement in midterm Lysholm score. SAGE Publications 2023-07-31 /pmc/articles/PMC10392310/ http://dx.doi.org/10.1177/2325967123S00062 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc-nd/4.0/This open-access article is published and distributed under the Creative Commons Attribution - NonCommercial - No Derivatives License (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits the noncommercial use, distribution, and reproduction of the article in any medium, provided the original author and source are credited. You may not alter, transform, or build upon this article without the permission of the Author(s). For article reuse guidelines, please visit SAGE’s website at http://www.sagepub.com/journals-permissions.
spellingShingle Article
Shankar, Dhruv
Vasavada, Kinjal
Kingery, Matthew
Montgomery, Samuel
Buzin, Scott
Chan, Calvin
Jazrawi, Laith
Strauss, Eric
Avila, Amanda
Paper 36: Levels of Synovial Fluid Cytokines Predict Midterm Patient Reported Outcomes Following Arthroscopic Partial Meniscectomy
title Paper 36: Levels of Synovial Fluid Cytokines Predict Midterm Patient Reported Outcomes Following Arthroscopic Partial Meniscectomy
title_full Paper 36: Levels of Synovial Fluid Cytokines Predict Midterm Patient Reported Outcomes Following Arthroscopic Partial Meniscectomy
title_fullStr Paper 36: Levels of Synovial Fluid Cytokines Predict Midterm Patient Reported Outcomes Following Arthroscopic Partial Meniscectomy
title_full_unstemmed Paper 36: Levels of Synovial Fluid Cytokines Predict Midterm Patient Reported Outcomes Following Arthroscopic Partial Meniscectomy
title_short Paper 36: Levels of Synovial Fluid Cytokines Predict Midterm Patient Reported Outcomes Following Arthroscopic Partial Meniscectomy
title_sort paper 36: levels of synovial fluid cytokines predict midterm patient reported outcomes following arthroscopic partial meniscectomy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392310/
http://dx.doi.org/10.1177/2325967123S00062
work_keys_str_mv AT shankardhruv paper36levelsofsynovialfluidcytokinespredictmidtermpatientreportedoutcomesfollowingarthroscopicpartialmeniscectomy
AT vasavadakinjal paper36levelsofsynovialfluidcytokinespredictmidtermpatientreportedoutcomesfollowingarthroscopicpartialmeniscectomy
AT kingerymatthew paper36levelsofsynovialfluidcytokinespredictmidtermpatientreportedoutcomesfollowingarthroscopicpartialmeniscectomy
AT montgomerysamuel paper36levelsofsynovialfluidcytokinespredictmidtermpatientreportedoutcomesfollowingarthroscopicpartialmeniscectomy
AT buzinscott paper36levelsofsynovialfluidcytokinespredictmidtermpatientreportedoutcomesfollowingarthroscopicpartialmeniscectomy
AT chancalvin paper36levelsofsynovialfluidcytokinespredictmidtermpatientreportedoutcomesfollowingarthroscopicpartialmeniscectomy
AT jazrawilaith paper36levelsofsynovialfluidcytokinespredictmidtermpatientreportedoutcomesfollowingarthroscopicpartialmeniscectomy
AT strausseric paper36levelsofsynovialfluidcytokinespredictmidtermpatientreportedoutcomesfollowingarthroscopicpartialmeniscectomy
AT avilaamanda paper36levelsofsynovialfluidcytokinespredictmidtermpatientreportedoutcomesfollowingarthroscopicpartialmeniscectomy